Intuitive Surgical (NASDAQ:ISRG) had its price target hoisted by investment analysts at Morgan Stanley from $450.00 to $500.00 in a note issued to investors on Friday. The brokerage presently has an “overweight” rating on the medical equipment provider’s stock. Morgan Stanley’s target price indicates a potential upside of 13.57% from the company’s current price.
ISRG has been the topic of a number of other reports. Wedbush reaffirmed a “buy” rating on shares of Intuitive Surgical in a research note on Tuesday, October 10th. Barclays reaffirmed an “overweight” rating on shares of Intuitive Surgical in a research note on Friday, October 20th. Zacks Investment Research raised shares of Intuitive Surgical from a “hold” rating to a “strong-buy” rating and set a $437.00 price target on the stock in a research note on Tuesday, December 12th. ValuEngine downgraded shares of Intuitive Surgical from a “hold” rating to a “sell” rating in a research note on Friday, December 29th. Finally, Evercore ISI started coverage on shares of Intuitive Surgical in a research note on Wednesday, January 3rd. They issued an “in-line” rating and a $380.00 price target on the stock. One investment analyst has rated the stock with a sell rating, six have issued a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company. Intuitive Surgical has a consensus rating of “Buy” and an average price target of $409.40.
Intuitive Surgical (ISRG) traded down $9.57 on Friday, hitting $440.24. The stock had a trading volume of 1,811,296 shares, compared to its average volume of 1,046,033. The stock has a market capitalization of $50,400.00, a price-to-earnings ratio of 56.88, a P/E/G ratio of 5.22 and a beta of 0.47. Intuitive Surgical has a one year low of $227.38 and a one year high of $452.00.
In other Intuitive Surgical news, CFO Marshall Mohr sold 6,000 shares of the stock in a transaction on Monday, October 30th. The shares were sold at an average price of $372.22, for a total transaction of $2,233,320.00. Following the transaction, the chief financial officer now directly owns 12,316 shares of the company’s stock, valued at $4,584,261.52. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, SVP Mark J. Meltzer sold 3,000 shares of the stock in a transaction on Monday, November 27th. The stock was sold at an average price of $400.00, for a total transaction of $1,200,000.00. Following the transaction, the senior vice president now directly owns 9,888 shares in the company, valued at $3,955,200. The disclosure for this sale can be found here. Insiders have sold 28,621 shares of company stock worth $11,216,568 over the last three months. Company insiders own 2.20% of the company’s stock.
A number of institutional investors have recently bought and sold shares of ISRG. Thrivent Financial For Lutherans grew its position in shares of Intuitive Surgical by 3.0% in the second quarter. Thrivent Financial For Lutherans now owns 1,390 shares of the medical equipment provider’s stock valued at $1,300,000 after purchasing an additional 40 shares during the last quarter. Nordea Investment Management AB grew its position in shares of Intuitive Surgical by 0.6% in the second quarter. Nordea Investment Management AB now owns 1,952 shares of the medical equipment provider’s stock valued at $1,826,000 after purchasing an additional 12 shares during the last quarter. Advisor Group Inc. grew its position in shares of Intuitive Surgical by 43.2% in the second quarter. Advisor Group Inc. now owns 1,554 shares of the medical equipment provider’s stock valued at $1,363,000 after purchasing an additional 469 shares during the last quarter. Zacks Investment Management acquired a new stake in shares of Intuitive Surgical in the second quarter valued at about $597,000. Finally, Numeric Investors LLC grew its position in shares of Intuitive Surgical by 2.5% in the second quarter. Numeric Investors LLC now owns 2,090 shares of the medical equipment provider’s stock valued at $1,955,000 after purchasing an additional 50 shares during the last quarter. 33.11% of the stock is currently owned by hedge funds and other institutional investors.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
